35
Views
14
CrossRef citations to date
0
Altmetric
Review

Neuropeptide Y receptor antagonists in obesity

&
Pages 1827-1838 | Published online: 23 Feb 2005

Bibliography

  • TATEMOTO K, CARLQUIST M, MUTT V: Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 296:659–660.
  • •First identification of NPY.
  • TATEMOTO K: Neuropeptide Y: complete amino acid se-quence of the brain peptide. Proc, Nati, Acad, Sci, USA (1982) 79:5485–5489.
  • TATEMOTO K: Isolation and characterization of peptideYY (PYY), a candidate gut hormone that inhibits pan-creatic exocrine function. Proc, NatL Acad. Sci, USA (1982) 79:2514–2418.
  • KIMMEL JR, POLLOCK HG, HAZELWOOD RL: Isolationand characterization of chicken insulin. Endocrinology (1968) 83:1323–1330.
  • LIN T-M, CHANCE RE, CHEY WY, BROOKS FP: Gastroin-testinal actions of a new bovine pancreatic peptide (BPP). In: Endocrinology of the Gut, Chey, Brooks (Eds.), Charles B Slack, Inc., Thorofare, NJ (1974):143–145.
  • BLUNDELL TL, PITTS JE, TICKLE IJ, WOOD SP, WU C-W: X-ray analysis (1.4 A resolution) of avian pancreatic polypeptide: small globular protein hormone. Proc, Natl. Acad. Sci, USA (1981) 78:4175–4179.
  • DIMAGGIO DA, CHRONWALL BM, BUCHMAN K,O'DONOHUE TL: Pancreatic polypeptide immunoreac-tivity in rat brain is actually neuropeptide Y. Neurosci-ence (1985) 15:1149–1157.
  • ALLEN YS, ADRAIN TE, ALLEN JM et al.: Neuropeptide Ydistribution in the rat brain. Science (1983) 221:877–879.
  • CHRONWALL BM, DIMAGGIO DA, MASSARI VJ et al.: Theanatomy of neuropeptide Y-containing neurons in the rat brain. Neuroscience (1985) 15:1159–1181.
  • O'DONOHUE TL, CHRONWALL BM, PRUSS RM etal.: Neu-ropeptide Y and peptide YY in neuronal and endocrine systems. Peptides (1985) 6:755–768.
  • LARHAMMAR D: Evolution of neuropeptide Y, peptideYY and pancreatic polypeptide. ReguL Pept, (1996) 62:1–11.
  • DE QUIDT ME, EMSON PC: Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous sys-tem II. Immunohistochemical analysis. Neuroscience (1986) 18:545–618.
  • GRUNDEMAR L, HAKANSON R: Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Pe-ripheral and central mechanisms. Gen. Pharmacol. (1993) 24:785–796.
  • MCDERMOTT BJ, MILLAT BC, PIPER HM: Cardiovasculareffects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc, Res. (1993) 27:893–905.
  • SAHU A, KALRA SP: Neuropeptidergic regulation of feed-ing behavior by neuropeptide Y. Trends Endocrinol, Me-tab. (1993) 4:217–224.
  • STANLEY BG, MAGDALIN W, SEIRAFI A, THOMAS WJ, LEI-BOWITZ SF: The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. (1993) 604:304–317.
  • KALRA SP, DUBE MG, KALRA PS: Continuous intraven-tricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalec-tomy and cholecystokinin. Peptides (1988) 9:723–728.
  • STANLEY BG, LANTHIER D, CHIN AS, LEIBOWITZ SF: Sup-pression of neuropeptide Y-elicited eating by ad-renalectomy or hypophysectomy: reversal with corticosterone. Brain Res. (1989) 501:32–36.
  • BECK B, STRICKER-KRONGRAD A, NICOLAS JP, BURLET C: Chronic and continuous intracerebroventricular infu-sion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int. J. Obesity 0994 16:295–302.
  • PAEZ X, MYERS RD: Insatiable feeding evoked in rats by recurrent perfusion of neuropeptide Y in the hypo-thalamus. Peptides (1991) 12:609–616.
  • ZARJEVSKI N, CUSIN I, VETTOR R et al.: Chronic in-tracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology (1993) 133:1753–1758.
  • •First conclusive demonstration that NPY has direct endocrine effects that contribute to NPY-induced obesity.
  • BERRETTINI WH, KAYE WH, GWIRTSMAN H, ALLBRIGHT A: Cerebrospinal fluid peptide YY immunoreactivity in eating disorders. Neuropsychobiology (1988) 19:121–124.
  • KAYE WH, BERRETTINI WH, GWIRTSMAN H, GEORGE DT: Altered cerebrospinal fluid neuropeptide Y and pep-tide YY immunoreactivity in anorexia and bulimia ner-vosa. Arch. Gen. Psychiat (1990) 47:548–556.
  • HAZELWOOD RL: The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behav-ioral implications. P.S.E.B.M (1993) 202:44–63.
  • LABURTHE M: Peptide YY and neuropeptide Yin the in-testine: availability, biologic effect and epithelial recep-tors. Archives Intemationales de Physiologie, de Biochimie et de Biophysique (1991) 99:A177–A192.
  • VOISIN T, ROUYER-FESSARD C, LABURTHE M: Distribu-tion of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis. Am. J. Physiol. (1990) 258:G753–G759.
  • EKMAN R, WAHLESTEDT C, BOTTCHER G et al.: Peptide YY-like immunoreactivity in the central nervous sys-tem of the rat. ReguL Pept. (1986) 16:157–168.
  • BROOME M, HOKFELT T, TERENIUS L: Peptide YY (PYY) immunoreactive neurons in the lower brainstem and spinal cord of the rat. Acta Physiol. Scand. (1985) 125:349–352.
  • LIN TM, CHANCE RE: Spectrum of gastrointestinal ac-tions of bovine PP. In: Gut Hormones Bloom SR (Eds.), Churchill Livingston, London, UK (1978):
  • LIN TM, EVANS DC, CHANCE RE, SPRAY GF: Bovine pan-creatic polypeptide: action on gastric and pancreatic secretion in dogs. Am. J. Physiol. (1977) 232:E311–E315.
  • HAZELWOOD RL: Biosynthesis, chemistry and storage of islet (endocrine) products. In: The Endocrine Pancreas. Hadley ME (Eds.), Prentice Hall, Eaglewood Cliffs, NJ (1989).
  • LOUIE DS, WILLIAMS JA, OWYANG C: Action of pancre-atic polypeptide on rat pancreatic secretion: in vivo and in vitro. Am. J. Physiol. (1985) 249:G489–G495.
  • GROSSMAN MI, BROWN JC, SAID S et al.: Candidate hor-mones of the gut. Gastroenterology (1974) 67:730–755.
  • CLARK JT, KALRA PS, CROWLEY WR, KALRA SP: Neuro-peptide Y and human pancreative polypeptide stimu-late feeding behavior in rats. Endocrinology (1984) 115:427–429.
  • WHITCOMB DC, PUCCIO AM, VIGNA SR, TAYLOR IL, HOFFMAN GE: Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res. (1997) 760:137–149.
  • GEHLERT DR, SCHOBER DA, GACKENHEIMER SL et al.: 1253134i [ 11-Leu -Pro -PYY s a high affinity radioligand for rat PP1 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides (1997) 18:397–401.
  • EVA C, KEINANEN K, MONYER H, SEEBURG P, SPRENGELR: Molecular cloning of a novel G-protein-coupled re-ceptor that may belong to the neuropeptide receptor family. FEBS Letts. (1990) 271:80–84.
  • LARHAMMAR D, BLOMQUIST AG, YEE F: Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 subtype. J. Blot Chem. (1992) 267:10935–10938.
  • HERZOG H, HORT YJ, BALL HJ et al.: Cloned human neu-ropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci, USA (1992) 89:5794–5798.
  • LARSEN PJ, SHEIKH SP, JAKOBSEN CR et al.: Regional dis-tribution of putative NPY Y1 receptors and neurons ex-pressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur, J. Neurosci, (1993) 5:1622–1637.
  • WAHLESTEDT C, YANAIHARA N, HAKANSON R: Evidence for different pre- and post-junctional receptors for neu-ropeptide Y and related peptides. Regut Pept, (1986) 13:307–318.
  • •First demonstration of Yl and Y2 receptor subtypes.
  • WAHLESTEDT C, EDVINSSON L, EKBLAD E, HAANSON R: Effects of neuropeptide Y at sympathetic neuroeffector junctions: existence of Yl- and Y2-receptors. In: Neu-ronal Messengers in Vascular Function. Nobin A, Owman C and Arneklo-Nobin B (Eds.), Elsevier, Amsterdam (1987):231–241.
  • MALMSTROM RE: Neuropeptide Y Yi receptor mecha-nisms in sympathetic vascular control. Acta PhysioL Scand. (1997) 160:1–55.
  • BROQUA P, WETTSTEIN JG, ROCHER MN, GAUTHIER-MARTIN B, JUNIEN JL: Behavioral effects of neuropep-tide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharmacol. (1995) 6:215–222.
  • HEILIG M, MCLEOD S, BROT M et al.: Anxiolytic-like ac-tion of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology (1993) 8:357–363.
  • FUHLENDORFF JU, GETHER U, AAKERLUND L et al.: [Leu31, Prom]neuropeptide Y - a specific Yi receptor agonist. Proc. Natl. Acad. Sci, USA (1990) 87:182–186.
  • GEHLERT DR, BEAVERS L, JOHNSON D et al.: Expression cloning of a human brain neuropeptide Y Y2 receptor. Mot Pharmacol. (1996) 49:224–228.
  • GERALD C, WALKER MW, VAYSSE PJ-J et al.: Expression cloning and pharmacological characterization of a hu-man hippocampal neuropeptideY/peptide YY Y2 re-ceptor subtype. J. Biol. Chem. (1995) 270:26758–26761.
  • ROSE PM, FERNANDES P, LYNCH JS: Cloning and expres-sion of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. (1995) 270:22661–22664.
  • DUMONT Y, FOURNIER A, ST-PIERRE S, QUIRION R: Char-acterization of a selective neuropeptide Y/peptide YY Y2 receptor ligand: [12511-PYY3-36. Soc. Neurosci, Abstr. (1993) 19:726.
  • BECK-SICKINGER AG, JUNG G: Structure-activity rela-tionships of neuropeptide Y analogues with respect to Yi and Y2 receptors. Biopolymers (Peptide Science) (1995) 37:123–142.
  • EWALD DA, STERNWEIS PC, MILLER RJ: Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons. Proc. Natl. Acad. Sci, USA (1988) 85:3633–3637.
  • BLEAKMAN D, HARRISON NL, COLMERS WF, MILLER RJ: In-vestigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol, (1992) 107:334–340.
  • WILEY JW, GROSS RA, MACDONALD RL: Agonists for neu-ropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite actions on rat nodose neuron calcium cur-rents. J. Neurophysiol, (1993) 70:324–330.
  • TOTH PT, BINDOKAS VP, BLEAKMAN D, COLMERS WF,MILLER RJ: Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature (1993) 364:635–639.
  • GEHLERT DR, GACKENHEIMER SL, SCHOBER DA: [Leu31-Pro34] Neuropeptide Y identifies a subtype of [125]I-labelled peptide YY binding sites in the rat brain. Neurochem, Int. (1992) 21:45–67.
  • DUMONT Y, FOURNIER A, ST-PIERRE S, QUIRION R: Com-parative characterization and autoradiographic distri-bution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. (1993) 13:73–86.
  • WAHLESTEDT C, HAKANSON R: Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and post-junctional receptors be distinguished? Med. Biol. (1986) 64:85–88.
  • STJERNQUIST M, OWMAN C: Further evidence for a pre-junctional action of neuropeptide Y on cholinergic mo-tor neurons in the rat uterine cervix. Acta Physiol, Scand. (1990) 138:95–96.
  • GRUNDEMAR L, GRUNDSTROM N, JOHANSSON IGM, AN-DERSSON RGG, HAKANSON R: Suppression by neuro-peptide Y of capsaicin-sensitive sensory nerve-mediated contraction in guinea pig airways. Br. J. Phar-macol. (1990) 99:473–476.
  • BARD JA, WALKER MW, BRANCHEK TA, WEINSHANK RL:Cloning and functional expression of a human Y4 sub-type receptor for pancreatic polypeptide, neuropep-tide Y and peptide YY. J. Biol. Chem. (1995) 270:26762–26765.
  • LUNDELL I, BLOMQVIST AG, BERGLUND M et al.: Cloningof a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. (1995) 270:29123–29128.
  • GEHLERT DR, SCHOBER DA, BEAVERS L et al.: Characteri-zation of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring re-ceptor. Mot Pharmacol, (1996) 50:112–118.
  • LUNDELL I, STATNICK MA, JOHNSON D et al.: The clonedrat pancreatic polypeptide receptor exhibits profound differences to the orthologus human receptor. Proc. Natl. Acad. Sci. (1996) 93:5111–5115.
  • GERALD C, WALKER MW, CRISCONE L et al.: A receptor subtype involved in neuropeptide-Y-induced food in-take. Nature (1996) 382:168–171.
  • ••First cloning of the Y5 receptor and association with the feed-ing effects of intracerebroventricular NPY.
  • HU Y, BLOOMQUIST BT, CORNFIELD LJ et al.: Identifica-tion of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. (1996) 271:26315–26319.
  • GREGOR P, FENG Y, DECARR LB, CORNFIELD LJ, MCCALEBML: Molecular characterization of a second mouse pan-creatic polypeptide receptor and its inactivated human homolog. I Biol. Chem. (1996) 271:27776–27781.
  • MATSUMOTO M, NOMURA T, MOMOSE K et al.: Inactiva-tion of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. (1996) 271:27217–27220.
  • WEINBERG DH, SIRINATHSINGHJI DJS, TAN CP et al.: Cloning and expression of a novel neuropeptide Y re-ceptor. J. Biol. Chem. (1996) 271:16435–16438.
  • GRUNDEMAR L, WAHLSTEDT C, REIS DJ: Neuropeptide Y acts at an atypical receptor to evoke cardiovascular de-pression and to inhibit glutamate responsiveness in the brainstem. J. PharmacoL Exp. Ther. (1991) 258:633–638.
  • GRUNDEMAR L, WAHLSTEDT C, REIS DJ: Long-lasting in-hibition of the cardiovascular responses to glutamate and the baroreceptor reflex elecited by neuropeptide Y injected into the nucleus tractus solitarius. Neurosci. Lett. (1991) 122:135–139.
  • BALASUBRAMANIAM A, SHERIFF S, RIGEL DF, FISCHER JE: Characterization of neuropeptide Y binding in rat car-diac ventricular membranes. Peptides (1990) 11:545–550.
  • WAHLESTEDT C, REGUNATHAN S, HAKANSON R: Identifi-cation of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci. (1992) 50:PL7-PL14.
  • HIGUCHI H, COSTA E, YANG W-Y: Neuropeptide Y inhib-its the acetylcholine-mediated release of catechola-mines from bovine adrenal chromaffin cells. J. PharmacoL Exp. Then (1988) 244:468–474.
  • VOISIN T, BENS M, CLUZEAUD F, VANDEWALLE A, LABUR-THE M: Peptide YY receptors in the proximal tubule PKSV-PCT cell line derived from transgenic mice. Biol. Chem. (1993) 268:20547–20554.
  • CASTAN I, VALET P, VOISIN T et al.: Identification andfunctional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology (1992) 131:1970–1976.
  • KALRA SP, DUBE MG, FOURNIER A, KALRA PS: Structure-function analysis of stimulation of food intake by neu-ropeptide Y: effects of receptor agonists. PhysioL Behav. (1991) 50:5–9.
  • STANLEY BG, MAGDALIN W, SEIRAFI A, NGUYEN MM, LEI-BOWITZ SF: Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Pep-tides (1992) 13:581–587.
  • KALRA SP, CROWLEY WR: Neuropeptide Y: a novel neu-roendocrine peptide in the control of pituitary hor-mone secretion and its relation to luteinizing hormone. Front. Neuroendocrinol. (1992) 13:1–46.
  • MIKKELSEN JD, LARSEN PJ: A high concentration of NPY(Yl)-receptor mRNA-expressing cells in the hypo-thalamic arcuate nucleus. Neuroscience Lett. (1992) 148:195–198.
  • SCHOBER DA, GEHLERT DR: Characterization of 125I neuropeptide Y as a novel radioligand for neuropep-tide Y receptors. Soc. Neurosci. Abstr. (1993) 19:727.
  • LOPEZ-VALPUESTA FJ, NYCE JW, GRIFFIN-BIGGS TA, ICE JC, MEYERS RD: Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypo-thermia and feeding in rats. Proc. Roy. Soc. Lond. (1996) 263:881–886.
  • HEILIG M: Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically in-creases feeding. ReguL Pept. (1995) 59:201–205.
  • PALMITER R, ERICKSON J, HOLLOPETER G, MARSH D: Role of neuropeptide Y in feeding and starvation. Summer Neuropeptide Conference (1997):62.
  • O'SHEA D, MORGAN DGA, MEERANS K et al.: Neuropep-tide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology (1997) 138:196–202.
  • DANIELS AJ, MATHEWS JE, SLEPETIS RJ et al.: High-affinity neuropeptide Y receptor antagonists. Proc. NatL Acad. Sci USA (1995) 92:9067–9071.
  • ••First high affinity peptide antagonist for the Y1 receptor.
  • KANATANI A, ISHIHARA A, ASAHI S et al.: Potent neuro-peptide Y Y1 receptor antagonist 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Endocrinology (1996) 137:3177–3182.
  • DOODS HN, WIELAND HA, ENGEL W et al.: BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. ReguL Pept. (1996) 65:71–77.
  • ••Review of the first nonpeptide antagonist for the Y1 receptor.
  • SERRADEIL-LE GAL C, VALEET G, ROUBY PE et al.: SR120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett. (1995) 362:192–196.
  • WRIGHT J, BOLTON G, CRESWELL M et al.: 8-Amino-6-(arylsulfony0-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists. Bioorg. Med. Chem. Lett. (1996) 6:1809–1811.
  • HIPSKIND PA, LOBB KU, NIXON JA et al.: Potent and selec-tive 1,2,3-trisubstituted indole NPY Y-1 antagonists. Med. Chem. (1997) 40:3712–3714.
  • MUNGLANI R, HUDSPITH MJ, HUNT SP: The therapeutic potential of neuropeptide Y. Drugs (1996) 52:371–389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.